Etravirine
10 NDCs across 5 manufacturers|8 Generic,2 Brand
Etravirine is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 18, 2008, and the first generic was approved Jun 14, 2021. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $25 million on Etravirine across 23,000 claims for 2,734 beneficiaries.
Etravirine is available as 10 NDCs from 5 manufacturers (8 generic, 2 brand), with NADAC prices from $7.77 to $24.30 per EA — the most expensive product costs about 3.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
8G / 2B
Manufacturers
5
competing in market
Price Spread
$7.77 – $24.30
per EA
7d Activity
avg -4.0% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
5 manufacturers producing ETRAVIRINE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INTELENCE 200 MG TABLET | $24.3032 per EA | — |
INTELENCE 100 MG TABLET | $10.9213 per EA | — |
ETRAVIRINE 200 MG TABLET | $10.7885 per EA | -4.04% |
ETRAVIRINE 200 MG TABLET | $10.7885 per EA | -4.04% |
ETRAVIRINE 200 MG TABLET | $10.7885 per EA | -4.04% |
ETRAVIRINE 200 MG TABLET | $10.7885 per EA | -4.04% |
ETRAVIRINE 100 MG TABLET | $7.7671 per EA | — |
ETRAVIRINE 100 MG TABLET | $7.7671 per EA | — |
ETRAVIRINE 100 MG TABLET | $7.7671 per EA | — |
ETRAVIRINE 100 MG TABLET | $7.7671 per EA | — |
Frequently Asked Questions
What is Etravirine used to treat?
Etravirine is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
When did Etravirine become available as a generic?
FDA approved the first generic Etravirine (ANDA) on Jun 14, 2021. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Etravirine?
In 2024, Medicare Part D spent $25 million on Etravirine across 23,000 claims for 2,734 beneficiaries.
How many Etravirine products are on the market?
The Etravirine drug market contains 10 NDCs from 5 manufacturers — 8 generic and 2 brand products.
What is the price range for Etravirine?
NADAC reference prices for Etravirine range from $7.7671 to $24.3032 per EA — the most expensive product costs about 3.1× the cheapest.
Is generic Etravirine cheaper than brand?
The average generic NADAC for Etravirine is $9.2778 per EA, versus $17.6123 for brand-labeled products — generic is about 47% cheaper on average.
Which manufacturers make Etravirine?
5 manufacturers list Etravirine in NADAC. Ranked by number of NDCs, the largest are Janssen Products LP (2), Bionpharma Inc. (2), Patriot Pharmaceuticals (2), Amneal Pharmaceuticals NY LLC (2), Leading Pharma, LLC (2).
How has the price of Etravirine changed recently?
Over the past 7 days, 0 Etravirine NDCs rose and 4 fell, with a market-wide average change of -4.0%.